Sinclair Research recently expanded its GLP nonclinical toxicology facility by adding additional research space dedicated to support nonclinical toxicology research. The new expansion increases our room capacity by more than 25 percent, allowing Sinclair to continue to offer rapid study starts and support increasing demand for outsourced drug development services. Coupled with our data capture technology and SEND-compliant reporting capabilities, our new expansion means Sinclair can generate quality, GLP-compliant data faster to support your next research program. Our new expanded research facility features include:
- More rooms for shorter study lead times: We have increased capacity by adding an additional 17 rooms, allowing for shorter lead times when you need to advance your research program. Whether you need discovery toxicology or are preparing an IND-enabling program, Sinclair can support your GLP toxicology research in small and large animal species.
- Flexibility by design: Featuring a mix of fixed and mobile housing options, our research rooms are designed with the flexibility you need to support your custom study designs across concurrent studies and programs. Our rooms offer multiple configurations and can easily support complex studies requiring special procedures.
- Expanded pathology services: Our new state-of-the-art necropsy suite features three trimming stations complete with electronic data collection technology to optimize data quality and accelerate the progression of your study through the tissue collections and processing stage.
In addition, our expanded research capabilities offer customers peace-of-mind through our fully-redundant on-site emergency backup power systems, as well as a fully computerized environmental control system to minimize environmental effects on your study program, and other improvements to help Sinclair Research continue to provide efficient and accurate GLP-compliant data for your studies.